| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Research and development | $4.6M+26.8% | $3.6M-42.5% | $6.3M-9.7% | $7.0M-21.1% | $8.9M+139.1% | $3.7M |
| General and administrative | $4.6M+22.9% | $3.7M-14.2% | $4.4M-1.9% | $4.5M-3.8% | $4.6M-8.9% | $5.1M |
| Total operating expenses | $9.2M+24.8% | $7.4M-31.8% | $10.8M-5.6% | $11.5M-15.2% | $13.5M+53.7% | $8.8M |
| Operating loss | -$9.2M-24.8% | -$7.4M+31.8% | -$10.8M+5.6% | -$11.5M+15.2% | -$13.5M-53.7% | -$8.8M |
| Interest income, net | $520K+125.1% | $231K | — | — | — | — |
| Other income, net | $2K-66.7% | $6K | — | — | — | — |
| Net loss | -$8.7M-21.7% | -$7.2M+34.0% | -$10.8M+5.7% | -$11.5M+13.6% | -$13.3M-51.1% | -$8.8M |
| Basic and diluted (in dollars per share) | -$1.45+84.0% | -$9.08+80.6% | -$46.76+99.5% | -$10100.00+18.7% | -$12430.00 | — |
| Basic and diluted (in shares) | 5.98B+659.9% | 787.5M+240.1% | 231.5M-79.6% | 1.14B+6.3% | 1.07B | — |
Source: SEC EDGAR XBRL. % change vs prior period shown where available.
Source: SEC EDGAR 10-K and 10-Q filings. Up to 10 years annual / 16 quarters shown.